KENILWORTH, N.J.– (BUSINESS WIRE)–In response to national trends showing that most people will develop an acute respiratory tract infection (RTI) every year, and with an estimated 55 percent of antibiotic prescriptions for RTI deemed excessive or unnecessary, RDx BioScience, a comprehensive full service laboratory, announces that its Respiratory Pathogen Panel provides rapid, accurate diagnostic testing to ensure appropriate prescribing. RDx BioScience cites data from the Centers for Disease Control that each year, two million Americans acquire serious bacterial infections that are resistant to one or more prescribed antibiotics, and at least 23,000 people die as a direct result of these antibiotic-resistant infections.
U.S. Antibiotic Awareness Week – Nov. 12-18
“Antibiotic resistance happens when bacteria develop the ability to defeat the drugs designed to kill them, posing one of the biggest public health challenges of our time,” says Scott Howell, D.O., MPH &TM, CPE, chief medical officer, RDx BioScience. “When the source of respiratory tract infections are viral in origin, antibiotics won’t work. RDx BioScience is working with physicians to utilize our Respiratory Pathogen Panel to prevent the spread of infection and eliminate the misuse of antibiotics, a threat which costs the U.S. healthcare system over $20 billion annually.”
In a single test, this fast, customizable FDA-cleared respiratory panel simultaneously detects 21 bacterial and viral pathogens from the upper and lower respiratory tract. Providing an overall sensitivity of 95 percent and specificity of 99 percent, the test enables rapid identification of secondary or multiple infections. The annual Centers for Disease Control and Prevention campaign, “Be Antibiotics Aware,” stresses antibiotics do not work on viruses, such as those that cause colds, flu, bronchitis or runny noses, even if the mucus is thick, yellow or green. Antibiotics should only be prescribed in the treatment of bacterial infections.
“Many commonly encountered respiratory pathogens — viral and bacterial — have similar clinical presentation, making a diagnosis on symptoms alone very difficult,” explains Dr. Howell. “The RDx BioScience Respiratory Pathogen Panel provides clinicians accurate identification of respiratory pathogens causing illness to effectively prescribe treatment. RDx BioScience respiratory assays can rapidly and efficiently detect relevant pathogens.”
About RDx BioScience
RDx is a full-service, high-technology laboratory. We are fast, accurate, and deliver value-based service nationally. RDx is accredited by the College of American Pathologists (CAP) as a certified, full-service medical laboratory. Visit www.RDxBioScience.com
CPR for RDx
Brittany Tedesco, 201-641-1911, x14